AndersenDA. Environmental factors in the aetiology of urolithiasis. In: CifuentesDLRapadoAHodgkinsonA, eds. Urinary Calculi: Proceedings of the Internatinal Symposium on Renal Stone Disease. Karger: Basel, 1973: 130–44.
TschopeWRitzEHaslbeckMMehnertHWeschH.Prevalence and incidence of renal stone disease in a German population sample. Klin Wochenschr1981; 59: 411–12.
4.
VahlesieckEWBachDHesseA.Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res1982; 10: 161–4.
5.
ScottR.Prevalence of calcified upper urinary tract stone disease in a random population survey. Brit J Urol1987; 59: 111–17.
6.
FrangosDNRousSN. Incidence and economic factors in urolithiasis. In: RousSN, ed. Stone Disease: Diagnosis and Management. New York: Grune & Stratton, 1987: 3–10.
7.
WilliamsRE. Long term survey of 538 patients with upper urinary tract stone. Brit J Urol1963; 35: 416–37.
8.
LjunghallSLDanielsonBG. A prospective study of renal stone recurrence. Brit J Urol1984; 56: 122–4.
9.
HendersonMJ. Renal stone disease—investigative aspects. Arch Dis Child1993; 68: 160–2.
10.
FinlaysonBKhanSRHackettR.Theoretical chemical models of urinary stones. In: WickhamJEABuckAC, eds. Renal Tract Stone—Metabolic Basis and Clinical Practice. London: Churchill Livingstone UK, 1990: 133–47.
11.
RyallRL. The scientific basis of calcium urolithiasis—predilection and precipitation, promotion and proscription. Wld J Urol1993; 11: 59–65.
12.
CoeFLParksJHAsplinJR. The pathogenesis and treatment of kidney stones. N Engl J Med1992; 327: 1141–52.
RoseGAWoodfineC.The thermogravimetric analysis of renal stones (in clinical practice). Brit J Urol1976; 48: 403–12.
15.
BerthelotMCornuGDaudonMHelbertMLaurenceC.Diffuse reflectance technique for infrared analysis of urinary calculi. Clin Chem1987; 33: 780–3.
16.
HesseAGergeleitMSchullerPMollerK.Analysis of urinary stones by computerised infrared spectroscopy. J Clin Chem Clin Biochem1989; 27: 639–42.
17.
VolmerMBolckAWolthersBGde RuiterAJDoornbosDAvan der SilkW.Partial least-squares regression for routine analysis of urinary calculus composition with Fourier Transform infrared analysis. Clin Chem1993; 39: 948–54.
18.
HallsonPCKasidasGPSamuellCT. Preparation of calibrant materials for renal calculi analysis—some problems solved. Comm Lab Med1993; 1: 5–6.
19.
WestburyEJOmenogorP.A quantitative approach to the analysis of renal calculi. J Med Lab Technol1970; 27: 462–74.
20.
HodgkinsonA.A combined qualitative and quantitative procedure for the chemical analysis of urinary calculi. J Clin Path1971; 24: 147–51.
21.
WestburyEJ. Some observations on the quantitative analysis of over 1000 urinary calculi. Br J Urol1974; 46: 215–27.
22.
HodgkinsonARobertsonWG. Chemical analysis of urinary calculi. Assoc Clin Pathol1982; Broadsheet No. 103.
23.
OhmanSLarssonLTiseliusH.Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem1992; 29: 59–63.
24.
BulusuLHodgkinsonA.Nordin BEC, Peacock M. Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculus. Clin Sci1970; 38: 601–12.
25.
LemannJAdamsNDGrayRW. Urinary calcium excretion in human beings. N Engl J Med1979; 301: 535–41.
26.
PremingerGM. The metabolic evaluation of patients with recurrent nephrolithiasis: A review of comprehensive and simplified approaches. J Urol1989; 141: 760–3.
27.
ModlinM.The interrelation of urinary calcium and sodium in normal adults. Invest Urol1966; 4: 180–9.
28.
SilverJFriedlanderMMRubingerDPopovtzerMM. Sodium dependent idiopathic hypercalciuria in renal stone formers. Lancet1983; ii: 484–6.
29.
SakhaeeKHarveyJAPadalinoPKWhitsonPPakCY. The potential role of salt abuse on the risk for kidney stone formation. J Urol1993; 150: 310–12.
30.
KasidasGPRoseGA. Continuous-flow assay for urinary oxalate using immobilised oxalate oxidase. Ann Clin Biochem1985; 22: 412–19.
31.
GoldsackKGinmanRFAWrightJM. Direct determination of urinary oxalate by a continuous flow method. Med Lab Sci1990; 47: 73–9.
HallsonPCRoseGA. A simplified and rapid enzymatic method for determination of urinary oxalate. Clin Chim Acta1974; 55: 29–39.
37.
HillmanRE. Primary Hyperoxaluria. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1989: 933–44.
38.
DanpureCJ. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis1991; 17: 366–9.
39.
GillHSRoseGA. Mild metabolic hyperoxaluria and its response to pyridoxine. Urol Int1986; 41: 393–6.
40.
BarrattTMKasidasGPMurdochIRoseGA. Urinary oxalate and glycolate excretion and plasma oxalate concentration. Arch Dis Child1991; 66: 501–3.
41.
FinchAMKasidasGPRoseGA. Urine composition in normal subjects after oral ingestion of oxalate rich foods. Clin Sci1981; 60: 411–18.
42.
StaufferJQ. Hyperoxaluria and intestinal disease. The role of steatorrhoea and dietary calcium in regulating intestinal oxalate absorption. Dig Dis1977; 22: 921–8.
43.
RamptonDSKasidasGPRoseGASarnerM.Oxalate loading test: A screening test for steatorrhoea. Gut1979; 20: 1089–94.
44.
AndersonHBosaeusI.Hyperoxaluria in malabsorptive states. Urol Int1981; 36: 1–9.
45.
HarperJMansellMA. Treatment of enteric hyperoxaluria. Postgrad Med J1991; 67: 219–22.
46.
RudmanDDedonisJLFountainMTChandlerJBGerronGGFlemingGAHypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med1980; 303: 657–61.
47.
KasidasGPRoseGA. The measurement of plasma oxalate and when this is useful. In: VahlensieckWGasserG, eds. Pathog Klin Harnsteine, Vol X11. Darmstadt: Steinkopf Verlag, 1987: 143–7.
48.
HallsonPCRoseGASulaimanS.Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int1983; 38: 179–81.
49.
KokDJPapapoulosSEBijvoetOLM. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet1986; i: 1056–8.
50.
MenonMMahleCJ. Urinary citrate excretion in patients with renal calculi. J Urol1983; 129: 1158–60.
51.
NicarMJSkurlaCSakhaeeKPakCYC. Low urinary citrate in nephrolithiasis. Urology1983; 21: 8–14.
52.
HoskingDHWilsonJWLLiedtkeRRSmithLHWilsonDM. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med1985; 106: 622–89.
53.
NikkilaMKoivulaTJokelaH.Urinary citrate excretion in patients with urolithiasis and normal subjects. Eur Urol1989; 16: 382–5.
54.
DedmonREWrongO.The excretion of organic anion in renal tubular acidosis with particular reference to citrate. Clin Sci1962; 22: 19–32.
55.
NormanMEFeldmanNICohnRMRothKSMcCurdyDK. Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Paed1978; 92: 394–400.
56.
FourmanPRobinsonJR. Diminished urinary excretion of citrate during deficiencies of potassium in man; preliminary communication. Lancet1953; ii: 656–7.
57.
RoseGA. Current trends in urolithiasis research. In: RousSN, ed. Stone Disease: Diagnosis and Management. New York: Grune and Stratton, 1987: 383–407.
58.
WangYGrenaboLHedelinHMcLeanRJCNickelJCPetterssonS.Citrate and urease-induced crystallisation in synthetic and human urine. Urol Res1993; 21: 109–15.
59.
HallsonPCRoseGASulaimanS.Urate does not influence the formation of calcium oxalate crystals in whole urine at pH 5.3. Clin Sci1982; 62: 421–5.
60.
GroverPKRyallRLMarshallVR. Effect of urate on calcium oxalate crystallisation in human urine: Evidence for a promotory role of hyperuricosuria in urolithiasis. Clin Sci1990; 79: 9–15.
61.
YuTF. Urolithiasis in hyperuricaemia and gout. J Urol1981; 126: 424–30.
62.
RodmanJSWilliamsJJPetersonCM. Dissolution of uric acid calculi. J Urol1984; 131: 1039–44.
63.
GillHSRoseGA. Idiopathic hypercalciuria: Urate and other ions in urine before and on various long term treatments. Urol Res1985; 13: 271–5.
64.
SimmondsHA. 2,8-Dihydroxyadeninuria- or when is a uric acid stone not a uric acid stone?Clin Neph1979; 20: 67–70.
BurrRGNuseibehI.The effect of oral acetohydroxamic acid on urinary saturation in stone forming paraplegic patients. Br J Urol1983; 55: 162–5.
67.
GrenaboLClaesGHedelinHPetterssonS.Rapidly recurrent renal calculi caused by Ureaplasma urealyticum: A case report. J Urol1986; 135: 995–7.
68.
GriffithDPMcCuePLeeHBensonJCarltonCE. Stone cancer: Paliative treatment with acetohyroxamic acid. Wld J Urol1983; 1: 170–5.
69.
MartelliABuliPSpataforaS.Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stone. Urology1986; 28: 373–5.
70.
KinoshitaKTakemotoMItataniHYachikuSKotakeTSonodaT.A new screening method for cystinuria. A simple and safe screening kit. Urol Int1979; 34: 369–73.
71.
ThuyLPNyhanWL. A screening method for cystine and homocystine in urine. Clin Chim Acta1992; 211: 175–9.
72.
BrandEHarrisMMBiloonS.The excretion of a cystine complex which decomposes in the urine with the liberation of free cystine. J Biol Chem1930; 86: 315–31.
73.
ByrdDJLindMBrodehlJ.Diagnostic and genetic studies in 43 patients with classic cystinuria. Clin Chem1991; 37: 68–73.
74.
GeorgesRJPolitzerWM. pH dependency of the cyanide nitroprusside colour reaction for cystine. Clin Chim Acta1970; 30: 737–40.
75.
SegalSThierSD. Cystinuria. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1989: 2479–96.
76.
MansellMA. Cystinuria, triamterene calculi, and stones in renal transplants. In: WickhamJEABuckAC, eds. Renal Tract Stone—Metabolic Basis and Clinical Practice. Churchill Livingstone, 1990: 425–37.
77.
RodmanJSBlackburnPWilliamsJJBrownAPopischilMAPetersonCM. The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Neph1984; 22: 273–8.
78.
JaegerPPortmanLSaundersARosenbergLEThierSO. Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med1986; 315: 1120–3.
79.
NormanRWMannetteWA. Dietary restriction of sodium as a means of reducing urinary cystine. J Urol1990; 143: 1193–5.
80.
HautmanR.Cystine-stone therapy with alpha-mercapto-propionylglycine. Experience with 99 patients. Wld J Urol1983; 1: 186–91.
81.
LotzMPottsJTBartterFC. Rapid simple method for determining effectiveness of D-penicillamine therapy in cystinuria. BMJ1965; 2: 521.
82.
HerringLC. Observations on the analysis of ten thousand urinary calculi. J Urol1962; 88: 545–62.
HolmesEWWyngaardenJB. Hereditary Xanthinuria. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1989: 1085–94.
86.
JoostJDopplerW.2,8-dihydroxyadenine stone in children. Urology1982; 20: 67–70.
87.
LamontagneAE. 2,8-dihydroxyadenine urolithiasis: Report of a case in a woman in the United States. J Urol1989; 142: 369–70.
HaddadFSKouyoumdjianA.Silica stone in humans. Urol Int1986; 41: 70–6.
90.
LeeMLeeYHsuTHChenMChangLS. Silica stone—development due to long term oral trisilicate intake. Scand J Urol Nephrol1992; 27: 267–9.
91.
EttingerBOldroydNOSorgelF.Renal calculi in triamterene users. In: SmithLHRobertsonWGFinlaysonB, eds. Urolithiasis—Clinical and Basic Research. New York: Plenum Press, 1981: 131–7.
92.
EmbonOMRoseGARosenbaumT.Chronic dehydration stone disease. Br J Urol1990; 66: 357–62.
93.
HallsonPCRoseGA. A new urinary test for stone ‘activity’. Br J Urol1978; 50: 442–8.
94.
RoseGA. Crystaluria as an aid to the study of urinary stones. Lab-Lore1982; 9: 738–40.
95.
Abdel-HalimRE. Crystalluria and its possible significance. Scand J Urol Nephrol1992; 27: 139–43.
96.
MazzachiBCTeubnerJKRyallRL. Factors affecting the measurement of urinary oxalate. Clin Chem1984; 30: 1339–43.
97.
KasidasGPRoseGA. Spontaneous in vitro generation of oxalate from L-ascorbate in some assays for urinary oxalate and its prevention. In: SchwillePOSmithLHRobertsonWGVahlensieckW, eds. Urolithiasis and Related Clinical Research. New York: Plenum, 1985: 653–6.
98.
KasidasGPRoseGA. Removal of ascorbate from urine prior to assaying with a commercial oxalate kit. Clin Chim Acta1987; 164: 215–21.
99.
NgRHMenonMLadensonJH. Collection and handling of 24-hour urine specimens for the measurement of analytes related to renal calculi. Clin Chem1984; 30: 467–71.
100.
CoeFLParksJHMooreES. Familial idiopathic hypercalciuria. N Engl J Med1979; 300: 337–40.
KaulPSidhuHVaidyanathanSThindSNathR.Study of urinary calcium excretion after oral calcium load in stone formers, their spouses and first-degree blood relatives. Urol Int1994; 52: 93–7.
103.
RyallRL. The formation and investigation of urinary calculi. Clin Biochem Revs1989; 10: 149–57.
104.
RyallRLMarshallVR. The investigation and management of idiopathic urolithiasis. In: WickhamJEABuckAC, eds. Renal Tract Stone: Metabolic Basis and Clinical Practice. London: Churchill Livingstone, 1990: 307–31.
105.
PremingerGM. Is there a need for medical evaluation and treatment of nephrolithiasis in the “age of lithotripsy”. Semin Urol1994; 12: 51–64.
106.
DanielsonBGBackmanUJohanssonGLjunghallSWikstromB.Prevention of stone recurrences with thiazide treatment. In: BrockisJGFinlaysonB, eds. Urinary Calculus.New York: PSG Publishing Co., 1979: 455–67.
107.
AhlstrandCTiseliusHGLarssonLHellgrenE.Clinical experience with long-term bendroflumenthiazide treatment in calcium oxalate stone formers. Br J Urol1984; 56: 255–62.
108.
PremingerGMPetersonRPetersPCPakCYC. The current role of medical treatment of nephrolithiasis: The impact of improved techniques of stone removal. J Urol1985; 134: 6–10.
109.
PakCYCFullerC.Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med1986; 104: 33–7.
110.
BuckCA. The epidemiology, formation, composition and medical management of idiopathic stone disease. Curr Opin Urol1993; 3: 316–22.
111.
DasGBaileyDMJFletcherMSBirchBCoptcoatMJWebbDR1500 cases of renal and ureteric calculi treated in an integrated stone centre. Br J Urol1988; 62: 301–5.
112.
LingemanJEWoodsJTothPDEvanAPMcAteerJA. The role of lithotripsy and its side effects. J Urol1989; 41: 793–7.
113.
KishimotoTSenjuMSugimotoTYamamotoKIimoriMKanasawaTEffects of high energy shock wave exposure on renal function during extracorporeal shock wave lithotripsy for renal stones. Eur Urol1990; 18: 290–8.
114.
KohrmannKURassweilerJAlkenP.The recurrence rate of stones following ESWL. Wld J Urol1993; 11: 26–30.
115.
LjunghallSFellstromBJohanssonG.Prevention of renal stones by a high fluid intake. Eur Urol1988; 14: 381–5.
116.
JaegerPPortmannLJacquetAFBurckhardtP.Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol1985; 5: 40–4.
117.
CurhanGCWillettWCRimmEBStampferMJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med1993; 328: 833–38.
118.
PakCYC. Should patients with single renal stone occurrence undergo diagnostic evaluation?J Urol1982; 127: 855–8.
119.
RyallRMarshallVR. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic. Br J Urol1983; 55: 1–5.